CADL
Price
$4.61
Change
-$0.31 (-6.30%)
Updated
Nov 13 closing price
Capitalization
251.97M
132 days until earnings call
Intraday BUY SELL Signals
RPTX
Price
$1.69
Change
-$0.03 (-1.74%)
Updated
Nov 13 closing price
Capitalization
72.82M
109 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CADL vs RPTX

Header iconCADL vs RPTX Comparison
Open Charts CADL vs RPTXBanner chart's image
Candel Therapeutics
Price$4.61
Change-$0.31 (-6.30%)
Volume$1.44M
Capitalization251.97M
Repare Therapeutics
Price$1.69
Change-$0.03 (-1.74%)
Volume$117.51K
Capitalization72.82M
CADL vs RPTX Comparison Chart in %
CADL
Daily Signal:
Gain/Loss:
RPTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CADL vs. RPTX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CADL is a Hold and RPTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (CADL: $4.61 vs. RPTX: $1.69)
Brand notoriety: CADL and RPTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CADL: 190% vs. RPTX: 78%
Market capitalization -- CADL: $251.97M vs. RPTX: $72.82M
CADL [@Biotechnology] is valued at $251.97M. RPTX’s [@Biotechnology] market capitalization is $72.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CADL’s FA Score shows that 0 FA rating(s) are green whileRPTX’s FA Score has 0 green FA rating(s).

  • CADL’s FA Score: 0 green, 5 red.
  • RPTX’s FA Score: 0 green, 5 red.
According to our system of comparison, RPTX is a better buy in the long-term than CADL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CADL’s TA Score shows that 4 TA indicator(s) are bullish while RPTX’s TA Score has 3 bullish TA indicator(s).

  • CADL’s TA Score: 4 bullish, 6 bearish.
  • RPTX’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, CADL is a better buy in the short-term than RPTX.

Price Growth

CADL (@Biotechnology) experienced а -6.68% price change this week, while RPTX (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.47%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +62.00%.

Reported Earning Dates

CADL is expected to report earnings on Mar 26, 2026.

RPTX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+1.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CADL($252M) has a higher market cap than RPTX($72.8M). RPTX YTD gains are higher at: 31.298 vs. CADL (-46.889). CADL has higher annual earnings (EBITDA): -19.74M vs. RPTX (-110.47M). RPTX has more cash in the bank: 109M vs. CADL (101M). RPTX has less debt than CADL: RPTX (649K) vs CADL (8.34M). RPTX has higher revenues than CADL: RPTX (250K) vs CADL (0).
CADLRPTXCADL / RPTX
Capitalization252M72.8M346%
EBITDA-19.74M-110.47M18%
Gain YTD-46.88931.298-150%
P/E RatioN/AN/A-
Revenue0250K-
Total Cash101M109M93%
Total Debt8.34M649K1,285%
TECHNICAL ANALYSIS
Technical Analysis
CADLRPTX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 3 days ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CADL
Daily Signal:
Gain/Loss:
RPTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BESVF152.24N/A
N/A
BE Semiconductor Industries N.V.
HKUOY14.90N/A
N/A
Hakuhodo Dy Holdings, Inc.
BDRXF17.25N/A
N/A
Bombardier Inc.
PRVFF4.17N/A
N/A
PRO REAL ESTATE INVT TR
BONXF0.14N/A
-2.17%
Bonterra Resources Inc.

CADL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with CYYNF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then CYYNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
-6.30%
CYYNF - CADL
46%
Loosely correlated
N/A
RPTX - CADL
43%
Loosely correlated
-1.74%
OSTX - CADL
35%
Loosely correlated
-5.21%
MDGL - CADL
33%
Poorly correlated
-2.65%
MRNA - CADL
31%
Poorly correlated
-6.55%
More

RPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with BCYC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then BCYC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
-0.58%
BCYC - RPTX
51%
Loosely correlated
-3.95%
INO - RPTX
50%
Loosely correlated
-2.00%
CADL - RPTX
43%
Loosely correlated
-1.99%
ALNY - RPTX
38%
Loosely correlated
+0.17%
AXON - RPTX
37%
Loosely correlated
-0.47%
More